Two infants exposed to anti-TNFα monotherapy (1 discontinued at week 30, 1 continued throughout pregnancy), had one event of pneumonia, and one was clinically diagnosed with pertussis despite immunizations, at age 10 months. The gene discussed is TNF; the disease is pertussis.